Startup Hyro announces appointment of three new VPs

Natural language and conversational AI startup Hyro, a graduate of the Intel Ignite accelerator, introduced a collection of senior appointments which have joined the corporate: Daniel Ben Tov as VP of Research and Development, Paz Yanover as VP of Product Management and Cathy Jones as VP of Sales.

Daniel Ben Tov will function VP of Research and Development. Ben Tov (37) joins Hyro from Atlassian, the place he served as Head of Engineering for the UI Platform.

1 View gallery

Paz Yanover, Cathy Jones, and Daniel Ben Tov.

(Photo: Hyro)

Paz Yanover will function VP of Product Management. Yanover (44) has 18 years of expertise working with enterprise software program merchandise in managerial, technical and practical roles. Prior to becoming a member of Hyro, Yanover served as Director of Product Management at Redis Labs and as VP of Product Management at Testim, just lately acquired by Tricentis for about $150 million.

Cathy Jones will function VP of Sales. Jones (63), has over 17 years of expertise within the fields of technique and gross sales in healthcare. Prior to becoming a member of Hyro, she served as VP of Sales and Sales Operations at Phynd Technologies Inc., from 2018 till Phynd was acquired by Symplr in 2021.

Israel Krush, CEO and Co-founder of Hyro, mentioned “As we proceed to strengthen our presence in healthcare, actual property, and the conversational AI business at giant, we’re thrilled to welcome proficient executives–and phenomenal individuals–like Cathy, Daniel and Paz. Their huge and distinctive experiences will assist us take Hyro from “early stage” to “early progress” as we turn out to be a market chief in our area.”

Hyro helps enterprises streamline their communications by means of numerous channels akin to customer support name facilities, chat interfaces on web sites, SMS and extra, by means of pure language processing automation (NLP Automation) capabilities and Conversational AI. The announcement of these senior appointments comes in the direction of the corporate’s Series B capital increase.

Related Posts